Superficial X-ray viable for basal, squamous cell carcinoma

August 6, 2012
Superficial X-ray viable for basal, squamous cell carcinoma
Superficial X-ray therapy remains a viable treatment for primary basal cell carcinoma and squamous cell carcinoma in select patients, according to a study published online July 23 in the Journal of the American Academy of Dermatology.

(HealthDay) -- Superficial X-ray therapy remains a viable treatment for primary basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) in select patients, according to a study published online July 23 in the Journal of the American Academy of Dermatology.

To examine the efficacy and viability of superficial X-ray therapy in the treatment of BCC and SCC, Armand B. Cognetta, M.D., from Dermatology Associates of Tallahassee in Florida, and colleagues conducted a retrospective analysis of 1,715 histologically confirmed primary cutaneous BCC and SCC among outpatients seen between 2000 and 2010. All tumors were treated with superficial X-ray therapy.

Of the tumors reviewed, the researchers found that 712 were histologically proven BCC (631 nodular and 81 superficial), 994 were SCC, and nine displayed features of both BCC and SCC. At two and five years, the cumulative recurrence rates were 1.9 and 5.0 percent, respectively, for all tumors; 2.0 and 4.2 percent, respectively, for all BCC; and 1.8 and 5.8 percent, respectively, for all SCC. There was a significantly increased likelihood of recurrence for tumors on male patients and tumors with a diameter greater than 2 cm.

"Superficial X-ray therapy remains a viable nonsurgical option for the treatment of primary BCC and SCC in patients where surgical intervention is declined, unadvisable, or potentially associated with significant cosmetic or ," the authors write.

One author disclosed financial ties to Sensus Health Care.

Explore further: Basal cell carcinoma on ear significantly more aggressive

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Basal cell carcinoma on ear significantly more aggressive

April 18, 2012
(HealthDay) -- Basal cell carcinoma (BCC) on the ear is significantly more likely to be aggressive, and occurs more frequently in men, according to a study published in the May issue of the Journal of the American Academy ...

Researchers find smoking is strongly associated with squamous cell carcinoma among women

December 8, 2011
Women who have non-melanoma skin cancers are more likely to have smoked cigarettes compared to women without skin cancer, said researchers at Moffitt Cancer Center in Tampa, Fla., who published study results in a recent issue ...

Study finds psoriasis treatment increases skin cancer risk

March 29, 2012
(HealthDay) -- The long-term risk of squamous cell carcinoma (SCC) is significantly increased for patients with severe psoriasis who receive more than 350 psoralen and ultraviolet A (PUVA) treatments compared with those who ...

Coffee consumption associated with decreased risk for basal cell carcinoma

October 24, 2011
Caffeine could be related to an inverse association between basal cell carcinoma risk and consumption of coffee, a study found.

Vitamin D levels appear to be associated with risk of skin cancer, although relationship is complex

August 15, 2011
As an individual's level of vitamin D increases, the risk of nonmelanoma skin cancer (NMSC) seems to increase as well, although factors such as ultraviolet (UV) radiation exposure may complicate the relationship, according ...

Sun exposure and cutaneous HPV infection found synergistic in skin cancers

June 25, 2012
Researchers at Moffitt Cancer Center and colleagues at the University of South Florida and the German Cancer Research Center in Heidelberg have found that having antibodies for cutaneous types of human papillomavirus (HPV), ...

Recommended for you

Targeted antibiotic use may help cure chronic myeloid leukaemia

September 19, 2017
The antibiotic tigecycline, when used in combination with current treatment, may hold the key to eradicating chronic myeloid leukaemia (CML) cells, according to new research.

Brain powered: Increased physical activity among breast cancer survivors boosts cognition

September 19, 2017
It is estimated that up to 75 percent of breast cancer survivors experience problems with cognitive difficulties following treatments, perhaps lasting years. Currently, few science-based options are available to help. In ...

Bone marrow protein a 'magnet' for passing prostate cancer cells

September 19, 2017
Scientists at the University of York have shown that a protein in the bone marrow acts like a 'magnetic docking station' for prostate cancer cells, helping them grow and spread outside of the prostate.

Brain cancer breakthrough could provide better treatment

September 19, 2017
A new discovery about the most common type of childhood brain cancer could transform treatment for young patients by enabling doctors to give the most effective therapies.

Researchers compose guidelines for handling CAR T cell side effects

September 19, 2017
Immune-cell based therapies opening a new frontier for cancer treatment carry unique, potentially lethal side effects that provide a new challenge for oncologists, one addressed by a team led by clinicians at The University ...

A new paradigm for treating transcription factor-driven cancers

September 18, 2017
In the current issue of Proceedings of the National Academy of Sciences, researchers from Nationwide Children's Hospital describe a new paradigm for treating transcription factor-driven cancers. The study focuses on Ewing ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.